Concepedia

Author

Anastasios Stathis

Institute of Oncology ResearchORCID

Also Known As

A Stathis, A. Stathis, Anastasios Stathis, Maria Cristina Pirosa, Stathis, A., Stathis, Anastasios

562

Publications

7.9K

Citations

39

H-Index

65

Concepts

All Affiliations

Institute of Oncology ResearchUniversità della Svizzera italianaSIB Swiss Institute of BioinformaticsUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro”Istituti di Ricovero e Cura a Carattere Scientifico
AS

About

Anastasios Stathis is an author at Institute of Oncology Research specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

36

2.1K

2

Health Sciences

9

9

210

3

Cell Biology

7

7

170

4

Biochemistry

1

1

20

5

Family Medicine

1

1

12

Anastasios Stathis

×

84

Publications

5.3K

Citations

34

H-Index

YearCitations

Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study

Sandy Amorim, Anastasios Stathis, Mary Gleeson,

The Lancet Haematology

2016

420

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial

Paolo F. Caimi, Weiyun Z. Ai, Juan Pablo Alderuccio,

The Lancet Oncology

2021

397

Clinical Response of Carcinomas Harboring the BRD4–NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628

Anastasios Stathis, Emanuele Zucca, Mohamed Békradda,

Cancer Discovery

2016

371

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

Valeria Spina, Alessio Bruscaggin, Annarosa Cuccaro,

Blood

2018

326

A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid Tumors

Philippe L. Bédard, Josep Tabernero, Filip Jankú,

Clinical Cancer Research

2014

318

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs

Michela Boi, Eugenio Gaudio, Paola Bonetti,

Clinical Cancer Research

2015

281

Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors

Jeremy Lewin, Jean‐Charles Soria, Anastasios Stathis,

Journal of Clinical Oncology

2018

267

Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma

Luca Ceriani, Maurizio Martelli, Pier Luigi Zinzani,

Blood

2015

171

Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type

Anastasios Stathis, Claudio Chini, Francesco Bertoni,

Annals of Oncology

2009

163

Histologic transformation in marginal zone lymphomas

Annarita Conconi, Silvia Franceschetti, Kathrin Aprile von Hohenstaufen,

Annals of Oncology

2015

122

Page 1